When we looked at the frequency of specific driver mutations between large and small tumors we only found two significantly enrichment genes (Fig. 5C), HRAS in small BLCA tumors and CDH1 in large BRCA tumors. This evidence concerns the gene HRAS and bladder transitional cell carcinoma.